|Articles|June 14, 2013
Strategic Outsourcing Debate
Lisa Henderson discusses the debate around aligning of sponsor and CRO in a more integrated way to run clinical trials from a project or portfolio standpoint and gain efficiencies and ultimately save money.
Advertisement
Lisa Henderson on the debate surrounding strategic outsourcing, which is the aligning of sponsor and CRO in a more integrated way to run clinical trials from a project or portfolio standpoint and gain efficiencies and ultimately save money.
Additional links:
- April 2013 article,
Challenging the Value of Strategic Partnerships in Clinical Trial Outsourcing .
- PAREXEL's
Strategic Partnerships 2013 .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
2
ACT Brief: AI-Enabled End-to-End Trials, New Phase III Data in HIV, and a First-Line Shift in HER2-Positive Breast Cancer
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
5